Providers may recommend more aggressive dosing schedules, and some patients achieve truly transformative results
Yes, the IRS requires a valid prescription from a licensed healthcare provider for any medication to be considered a qualified medical expense
Will new obesity agents further limit or prevent lean muscle mass reduction
Additionally, if you have a history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy (for people with diabetes), these factors require careful evaluation before prescribing GLP-1 receptor agonists
Indeed, considerable overlap was observed between the exposure-response seen with once-daily oral semaglutide (7 and 14 mg) and that seen with once-weekly s.c
Our clinical trials have demonstrated the effectiveness of Semaglutide GLP-1 in weight loss for individuals with a BMI of 30 or higher